AI chatbot could spot breast cancer genes before doctors do

NCT ID NCT07070128

Recruiting now Diagnosis Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Dec 18, 2025 · Last updated Apr 30, 2026 · Updated 14 times

Summary

This study is testing a new AI tool that collects family cancer history through WhatsApp to predict a woman's genetic risk for breast cancer. Researchers will compare the AI's predictions with standard genetic tests in 800 women already identified as high-risk by their doctors. The goal is to see if the AI can accurately identify who needs genetic counseling, potentially making risk assessment faster and more accessible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
WITHDRAWN

Golania, Goiás, 74605-020, Brazil
Research Site
RECRUITING

Porto Alegre, Rio Grande do Sul, 90035-001, Brazil
Research Site
NOT_YET_RECRUITING

Porto Alegre, Rio Grande do Sul, 90035-903, Brazil

Conditions

Explore the condition pages connected to this study.

BREAST NEOPLASMS BREAST NEOPLASMS